Archives
OSMI-1: A Causal Map for O-GlcNAc Assays
2026-08-22
OSMI-1 is a cell-permeable O-GlcNAc transferase inhibitor for dissecting protein O-GlcNAc modification and ferroptosis-linked signaling. This guide translates a new HUWE1–TfR1 study into a rigorous assay strategy while clarifying dose, toxicity, and interpretation limits.
EZ Cap™ Human PTEN mRNA (ψUTP): Translational Guide
2026-08-21
PTEN restoration is emerging as a practical strategy for interrogating PI3K/Akt-driven resistance. This thought-leadership article connects PTEN biology with the Cap1, pseudouridine-modified design of an in vitro transcribed mRNA reagent, examines evidence from nanoparticle-enabled trastuzumab-resistance research, and provides a translational framework for validating pathway inhibition without overstating preclinical findings.
Sulfur Supply Delays Soybean Nodule Senescence
2026-08-20
This study identifies sulfur delivery into the soybean symbiosome as a regulatory checkpoint for nodule longevity. Genetic and elemental analyses connect SULTR-mediated sulfur transport with glutathione-dependent reactive nitrogen species control, showing how sulfur supply can preserve symbiotic nitrogen fixation under high-nitrogen stress.
Deferoxamine mesylate for Iron-Stress Assays
2026-08-20
Build cleaner ferroptosis, hypoxia, cancer, and tissue-protection experiments by controlling labile iron rather than measuring oxidative damage after the fact. This workflow-focused guide covers concentration selection, HIF-1α stabilization, assay controls, and troubleshooting for reproducible iron biology.
Bromodomain Inhibitor, (+)-JQ1: Applied Workflows
2026-08-19
Bromodomain Inhibitor, (+)-JQ1 connects BET-dependent chromatin control with practical adipogenesis, oncology, inflammation, and reproductive-biology assays. This guide translates super-enhancer findings into a reproducible workflow while providing solvent, dosing, readout, and troubleshooting strategies.
MOG (35-55) for EAE and MS Research
2026-08-19
MOG (35-55) provides a defined antigenic trigger for reproducible experimental autoimmune encephalomyelitis, while supporting mechanistic studies of neuroinflammation and immune-modulating therapies. This workflow connects disease scoring with interferon-pathway assays inspired by recent PARP7–STAT1/2 findings.
Pioglitazone PPARγ Agonist Research Workflows
2026-08-18
Pioglitazone enables controlled interrogation of PPARγ-dependent metabolic, inflammatory, and cell-protective pathways. This workflow-centered guide connects receptor activation to macrophage polarization, beta-cell protection, and translational disease-model readouts while emphasizing solubility control and assay validation.
Why (R)-MG132 Matters in Cancer Metabolism
2026-08-18
A translational perspective on how (R)-MG132 strengthens proteasome inhibition validation in studies of HNRNPU lactylation, PHGDH regulation, and cervical cancer metabolism.
MK-1775: Rethinking Wee1 Checkpoint Biology
2026-08-17
A translational perspective on how MK-1775 converts Wee1 biology into a measurable research strategy, from checkpoint abrogation and p53 context to better interpretation of in vitro drug responses.
CCK8 Workflow for OSCC Viability Studies
2026-08-17
CCK8 converts viable-cell dehydrogenase activity into a water-soluble formazan signal, enabling streamlined proliferation, viability, and cytotoxicity testing. This workflow shows how to use Cell Counting Kit-8 alongside glycolysis measurements and EP300 perturbation to strengthen mechanistic cancer research conclusions.
Q-VD(OMe)-OPh for Reliable Apoptosis Assays
2026-08-16
This scenario-driven guide shows how Q-VD(OMe)-OPh (SKU A8165) can improve interpretation of viability, proliferation, and cytotoxicity experiments by providing a broad-spectrum caspase-inhibition control. It covers pathway attribution, solvent compatibility, protocol optimization, data interpretation, and practical reagent selection.
Turning Weak Signals Into Translational Evidence
2026-08-15
Tyramide signal amplification can convert faint molecular signals into spatially interpretable evidence. This thought-leadership article connects the mechanism of fluorescein TSA with the BMPSB4 study in corticotroph pituitary neuroendocrine tumors and outlines a disciplined strategy for validating low-abundance targets in translational tissue workflows.
Tin Mesoporphyrin IX: HO Assay Workflows
2026-08-14
Tin Mesoporphyrin IX (chloride) enables controlled, competitive inhibition of heme oxygenase for enzyme, metabolic, and HBV mechanism studies. This practical guide connects assay design with HO-1-mediated ROS experiments while emphasizing controls, solubility, and interpretation limits.
DZNep: Epigenetic Leverage for Translational Oncology
2026-08-14
3-Deazaneplanocin (DZNep) connects SAHH inhibition with EZH2 depletion and reduced H3K27 trimethylation, giving translational researchers a mechanistically distinctive platform for studying AML apoptosis, tumor-initiating cell biology, hepatocellular carcinoma, and context-dependent epigenetic responses.
MK-1775 Workflow for Wee1 Kinase Research
2026-08-13
Build more informative MK-1775 assays by separating growth inhibition from true cell killing and by pairing checkpoint biology with time-resolved readouts. This workflow helps researchers test DNA-damage combinations, verify p53-context effects, and troubleshoot solvent, timing, and endpoint artifacts.
610 records 11/41 page Previous Next First page 上5页 1112131415 下5页 Last page